NCT05768958Completed
Hedonic and Homeostatic Appetite Control in Obesity and Type 2 Diabetes in the Context of Meal and Exercise Timing
Source: ClinicalTrials.gov · Last updated 19 Oct 2026
Brief summary (registry, in English)
The overall aim is to investigate effects of acute exercise on ad libitum energy intake and study whether this differs between morning and evening in individuals with overweight/obesity with or without type 2 diabetes (T2D). Furthermore, the aim is to examine the role of hedonic and homeostatic drivers of appetite control in obesity and T2D in the context of meal and exercise timing.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 58 (actual)
- First submitted
- 15 Feb 2023
- Start date
- 22 Mar 2023
- Primary completion date
- 21 Aug 2024
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Diseases
- Obesity, Type 2 diabetes
- NCT number
- NCT05768958
What you commit to
- Study type: Interventional
- Participants enrolled: 58
- From 22 Mar 2023 to the primary completion date, 21 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Self-reported weight change (\>5 kg) within three months prior to inclusion
- Treatment with antidepressants
- Treatment with fast acting insulin, combination insulin products and sulfonylureas
- Alcohol/drug abuse or in treatment with disulfiram (antabus) at time of inclusion
- Current treatment with medication which significantly affect appetite or energy balance (e.g., GLP-1 receptor agonists)
- Bariatric surgery
- Concomitant participation in intervention studies
Other illness
- Self-reported history of an eating disorder in the past 3 years
- Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, gastrointestinal, or psychiatric disease; diabetes or other endocrine disease; immunosuppression
Other
- Not able to eat ad libitum meal
- Not able to perform the exercise bout
- Daily smoking
- For women: Pregnancy / planned pregnancy (within the study period) / lactating
- Unable to understand the informed consent and the study procedures
- Incapable of understanding Danish
Who the study is looking for
- Adults with overweight or obesity (BMI \>25 kg/m2) with and without T2D
- HbA1c ≥48 mmol/mol for people with T2D
Age in the registry: 18 years to 75 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Steno Diabetes Center Copenhagen Coordinator of this site? Confirm its status | Herlev | Denmark | Unknown status |
Related publications
This page is information, not medical advice. Discuss any trial with your doctor.